MATERIAL EVENT4579.TTSE

RaQualia Pharma: change of representative director

Summary

RaQualia Pharma Inc. filed an extraordinary report via EDINET on 2024-12-13 16:00 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100UXZ5 ↗ · PDL1.0 · Not investment advice